Donate Join our community

What We Do

Medical and Scientific Advisors

HeatherApplebaumMDportraitHeather Lynn Appelbaum, M.D., FACOG
Obstetrics and Gynecology

Dr. Heather Appelbaum is a graduate of Emory University School of Medicine in Atlanta, Georgia. She completed her post-doctorate training at the Mt. Sinai School of Medicine in New York. She currently holds academic appointments at the Albert Einstein College of Medicine and Long Island Jewish Center/Cohen Children’s Hospital and sees patients at the Ann and Jules Gottlieb Women’s Comprehensive Health Center and Long Island Jewish Medical Center/Cohen Children’s Hospital in New York. An obstetrician and gynecologist, Appelbaum has a special interest in congenital anomalies of the reproductive tract, pediatric pelvic reconstructive surgery, pediatric and adolescent gynecologic surgery, minimally invasive/laparoscopic surgery, ovarian cysts, endometriosis, and polycystic ovarian syndrome.




Richard J. Auchus, M.D., Ph.D.
Associate Professor of Internal Medicine
Dr. Richard Auchus received his B.S. in chemistry from Massachusetts Institute of Technology and his medical degree and doctorate in pharmacology from Washington University. He completed an internship and residency in Internal Medicine at the University of Iowa Hospitals and Clinics and a fellowship in Endocrinology at the Wilford Hall USAF Hospital and the University of Texas Health Sciences Center in San Antonio. He did postdoctoral work and training at the University of California, San Francisco prior to joining the faculty at the University of Texas Southwestern Medical Center in Dallas, Texas.

Dr. Auchus has been the recipient of several awards and honors such as Burroughs Wellcome Clinical Scientist Award in Translational Research and the Jean D. Wilson, M.D. Award for Excellence in Scientific Mentoring at UT Southwestern. His memberships in professional organizations include the American College of Physicians/American Society of Internal Medicine, the Endocrine Society and the Dallas County Medical Society/Texas Medical Association. He has authored over 90 journal articles and book chapters, and he has presented at a diverse range of national and international conferences. His group is active in research projects ranging from basic chemical principles of steroid biosynthetic enzymes to clinical and translational investigation in disorders of the pituitary, adrenals, ovaries, and testes that cause hypertension, infertility, and obesity. The common theme of all his work is steroid and sterol biosynthesis and action with an emphasis on human diseases. He collaborates with a range of investigators spanning a broad range of science from clinical neurobiology to basic mechanisms of nematode lifecycles. His clinical interests also focus on pituitary, adrenal, and reproductive diseases that involve disorders of steroid production.

Azziz-4.07_l-45229Ricardo Azziz, M.D., M.P.H., M.B.A.

Reproductive Endocrinologist
Dr. Azziz is the Chief Officer of Academic Health and Hospital Affairs, State University of New York System Administration and formerly, President of the Medical College of Georgia (MCG). Dr. Azziz received a M.D. from the Pennsylvania State University College of Medicine, Hershey, PA. He completed a Residency in Obstetrics and Gynecology at The Georgetown University Hospital, Washington, DC; and a Fellowship in Reproductive Endocrine/Infertility at The Johns Hopkins University, School of Medicine, Baltimore Maryland. At UAB, Dr. Azziz also completed a Masters in Public Health (MPH) in 1995 and a Masters in Business Administration (MBA) in 2000.

Dr. Azziz is a former Chair of the Advisory Committee on Reproductive Health Drugs, of the U.S. Food and Drug Administration; and a member of the Reproductive Endocrinology Study Section of the National Institutes of Health. Dr. Azziz has published over 200 original articles, book chapters, and reviews. He is editor of the text, Practical Manual of Operative Laparoscopy and Hysteroscopy (along with Dr. Ana Murphy), published by Springer-Verlag, now in its second edition and translated into Chinese; and Editor-in-Chief of Androgen Excess Disorders in Women (along with Drs. John E. Nestler and Didier Dewailly), published by Lippincott-Raven. Dr. Azziz is an active reviewer for the Journal of Clinical Endocrinology and Metabolism, where he served as member of its Editorial Board from 1992-1996; and Fertility and Sterility, on whose Editorial Board he currently serves, among others. Dr Azziz’s research interests include the study of the polycystic ovary syndrome (PCOS, the non-classic adrenal hyperplasias (NCAH); the role of the adrenal in hyperandrogenic disorders; the genetics of hyperandrogenic disorders including PCOS and NCAH; the treatment of hirsutism; the regulation and physiology of adrenal androgens; and credentialing and cost-effectiveness of operative endoscopy for pelvic reconstruction. He is currently funded by the U.S. National Institutes of Health for some of these studies.

conteFelix Conte, M.D.

Pediatric Endocrinologist
Dr. Felix Conte is presently Professor Emeritus in Pediatrics at the University of California in San Francisco. Dr Conte is a graduate of Columbia University, New York University School of Medicine and was a resident in Pediatrics at Bellevue Hospital in New York City. Subsequently he was a fellow in pediatric endocrinology at Babies Hospital and University of California San Francisco (UCSF) under the tutelage of Dr Melvin Grumbach and Dr Selna Kaplan. In 1970, he was appointed as an Assistant Professor at UCSF and has worked together with them ever since. During his tenure at UCSF he has helped train over 100 fellows from all over the world and has published numerous articles and chapters about pediatric endocrine conditions. He has had a particular interest in children with atypical genitalia.

Diaz%20AlejandroAlejandro Diaz, M.D.

Pediatric Endocrinologist
Dr. Alejandro Diaz graduated from La Universidad del Valle in Cali, Colombia and was trained in general pediatrics at Miami Children’s Hospital. He completed his specialization in Pediatric Endocrinology at NewYork-Presbyterian Hospital/Weill Cornell Medical College. He remained at Cornell as an attending assistant professor in Pediatric Endocrinology. Dr. Diaz’s special interests are in the care of children with short stature, thyroid disorders, disorders of puberty, congenital adrenal hyperplasia, obesity, and diabetes. He has been involved in clinical research of patients with certain genetic conditions concerning growth failure and small birth weight (i.e. Bloom’s syndrome). He is also part of the multidisciplinary team involved in the care of individuals with congenital adrenal hyperplasia, Fanconi’s anemia, Bloom’s syndrome, and thalassemia. He has participated in research on congenital adrenal hyperplasia. Currently, he is involved in the development of research protocols on overweight children to help promote healthy weight and lifestyles.


futterweitWalter Futterweit, M.D.
Adult Endocrinologist
As a clinical endocrinologist and researcher with a particular interest in androgens and women’s health, Dr. Walter Futterweit has devoted the past 25 years to the study of polycystic ovary conditions (PCOD and PCOS) and their pathophysiology, treatment, and manifestations, as well as CAH and other diseases of androgen excess. Dr. Futterweit’s interest in androgens and women’s health stems from his early training as a clinical endocrinologist and researcher.

 After completing a Fellowship at Mt. Sinai Hospital and training at the Worcester Foundation of Experimental Biology, Dr. Futterweit received a 2-year NIH grant for the study of androgens utilizing the assay he had developed at the Worcester Foundation. Since then, he has participated in several symposia on PCOS, and published numerous articles, reviews, abstracts, textbook chapters, as well as a book on PCOD. Dr. Futterweit is currently a Clinical Professor of Medicine at the Mt. Sinai Medical Center and continues to be active in national and international meetings in developing proposed guidelines for endocrinologists who treat PCOS. He has been elected to the Advisory Board of Polycystic Ovarian Syndrome Association (PCOSA), a national organization of women with PCOS, as well as to the board of the Androgen Excess Society, and often lectures at their meetings.


Mitchell E. Geffner, M.D.
Pediatric Endocrinologist
Dr. Geffner is currently Professor of Pediatrics and Director of Fellowship Training in the Division of Endocrinology, Diabetes, and Metabolism at Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, and formerly the Chief of the Division of Pediatric Endocrinology at the Mattel Children’s Hospital at UCLA. He graduated from Queens College of the City University of New York in 1972 and from the Albert Einstein College of Medicine in 1975. Dr. Geffner was an intern, resident, and chief resident at the Los Angeles County-University of Southern California Medical Center between 1975-1979. He completed a three-year fellowship in Pediatric Endocrinology at UCLA between 1979-1982.

He remained at UCLA through December 31, 2001, having risen up the academic ladder to the rank of Professor in 1996. Under the mentorship of Drs. Solomon Kaplan, Barbara Lippe, and David Golde, Dr. Geffner developed a long-standing basic research interest in the general area of hormone resistance. More specifically, he has studied the mechanisms responsible for resistance to ACTH (in the triple A syndrome), thyroid hormones, growth hormone (Laron dwarfism), and combined GH and IGF-I resistance (African Efe Pygmies and HIV-1-infected children with growth failure). To date, Dr. Geffner has authored over 100 peer-reviewed publications and review articles. On a clinical level, his research interests have involved studies of new formulations, delivery systems, indications for GH therapy, and optimization of treatment for children with Type 2 diabetes mellitus. Dr. Geffner has had a career-long interest in medical and patient education. He served as the Chairman of the Program Directors’ Committee of the Lawson Wilkins Pediatric Endocrine Society (LWPES) for six years, and is currently on the LWPES Program and Education Committees. Dr. Geffner was recently named to the Endocrinology Sub-Board of the American Academy of Pediatrics. He is also a medical advisor to the Turner Syndrome Society of Southern California, a medical advisor on childhood panhypopituitarism for the MAGIC Foundation and the Pituitary Network, a member of the Scientific & Medical Advisory Board of the CARES Foundation, and a member of the National Steering Committee for the NIH-sponsored TODAY (Treatment Of type 2 Diabetes in Adolescents and Youth) trial and the Scientific Leadership Group of the NIH-sponsored Pediatric HIV AIDS Cohort Study (PHACS). Lastly, Dr. Geffner is co-editor of the current edition of “Principles and Practice of Pediatric Endocrinology” (formerly the Wilkins’ Textbook) and co-author of the chapters on Puberty and Hypoglycemia.

Books Written
Kappy M, Geffner M, Allen D (eds), Principles and Practice of Pediatric Endocrinology (1st ed). Charles C. Thomas, 2005.


Kim_Mimi_pic compressedMimi Susan Kim, M.D., M.Sc.
Pediatric Endocrinologist
Dr. Mimi Kim is a Pediatric Endocrinologist, clinician-scientist, and specialist in CAH at Children’s Hospital Los Angeles. She is a graduate of Brown University, and Dartmouth Medical School and did her medical residency in Pediatrics at RUSH University Medical Center, Chicago. She also recently received a Master of Science degree in Clinical, Biomedical & Translational Investigations at the University of Southern California in Los Angeles.

 As a staff clinician at the NIH from 2008 to 2009, Dr. Kim had the special opportunity to work with Dr. Deborah Merke, learning how to do clinical research in CAH. Since 2009, she has been an Assistant Professor of Clinical Pediatrics at the University of Southern California’s Keck School of Medicine, a KL2 Scholar at the Southern California Clinical and Translational Science Institute, the recipient of a competitive institutional pilot award in 2012 for work involving imaging and metabolism, and has submitted a national K23 award to the National Institute of Child Health and Human Development. In conjunction with Dr. Mitchell Geffner, she has published the results of two of major CAH studies: the first showed significantly lower epinephrine levels in newborns with classical CAH, and the second showed significantly higher amounts of abdominal fat in adolescents with classical CAH. They continue to pursue new knowledge in CAH with several open studies on obesity, adrenomedullary function, TART, infant illness, and newborn screening. They are currently following catecholamine levels from infancy through toddlerhood, with the support of a CARES Foundation grant.

As well, as Co-Director of the CAH Comprehensive Care Clinic at CHLA, it is Dr. Kim’s goal to integrate advanced clinical research with cutting-edge multidisciplinary care, broad education programs, and support groups for families. She is passionate about improving the lives of children and families living with CAH, and take care of close to half of the 180+ CAH patients seen at the center.


OLekarev professional photo (5)Oksana Lekarev, D.O.
Pediatric Endocrinologist
Dr. Lekarev is Assistant Professor of Pediatrics at Weill Cornell Medical College in New York City and Assistant Attending Pediatrician at New York-Presbyterian Hospital.  Dr. Lekarev received a BA in Linguistics from Barnard College of Columbia University and received her medical degree from the University of Medicine and Dentistry of New Jersey – School of Osteopathic Medicine.

She completed her Internship in Pediatrics at the Robert Wood Johnson Medical Center and went on to complete her Residency in Pediatrics at Tufts-New England Medical Center.  Dr. Lekarev then moved back to New York City where she completed a fellowship in Pediatric Endocrinology at Mount Sinai Medical Center. She remained at Mount Sinai for two more years as a faculty member in the Division of Adrenal Steroid Disorders, where she was actively involved in research, clinical practice and medical education.

Currently, Dr. Lekarev is Associate Medical Director for the Comprehensive Care Center for Congenital Adrenal Hyperplasia at Weill Cornell Medical Center.  The Comprehensive Center for Congenital Adrenal Hyperplasia (CAH) is recognized as the nation’s first Center of Excellence by the CARES Foundation.

Dr. Lekarev’s areas of interest include adrenal steroid disorders, particularly Congenital Adrenal Hyperplasia, disorders of growth, disorders of pubertal development, and thyroid disease. She has published a number of original and review articles in peer-reviewed journals and has presented her work at national and international meetings.


Karen Jane Loechner, M.D./Ph.D.
Pediatric Endocrinologist
Dr. Loechner is an Assistant Professor in the Department of Pediatrics within the Division of Pediatric Endocrinology at the University of North Carolina, Chapel Hill.

She is the Director of the UNC Pediatric Osteoporosis Clinic and the Principal Investigator for an ongoing clinical trial entitled “CAH: Calcium Channels as Therapeutic Targets”. A second clinical trial to study bone health and the risk for osteoporosis in children with CAH is in preparation.

In parallel, Dr. Loechner directs a program of basic research examining mechanisms of calcium channel regulation of ACTH release and pituitary function. Supported by the March of Dimes, National Institutes of Health (NIDDK), and the CARES Foundation.

Dr. Loechner is a member of the American Association of Pediatrics, The Endocrine Society, and The Lawson Wilkins Society for Pediatric Endocrinology


Marshall photoIan Marshall, M.D.
Pediatric Endocrinologist

Dr. Marshall is Chief of the Division of Pediatric Endocrinology, and Associate Professor in the Department of Pediatrics at Rutgers-Robert Wood Johnson Medical School, NJ. Dr. Marshall graduated from the University of Cape Town Medical School, South Africa.  After immigrating to the USA, he completed a pediatric residency at Cohen Children’s Medical Center (formerly Schneider Children’s Hospital), New York, followed by a pediatric endocrine fellowship at New York Presbyterian Hospital – Weill Cornell Medical College.  Dr. Marshall has co-authored numerous peer reviewed articles, and medical chapters, and has contributed to the development of guidelines for comprehensive care centers for CAH.


WLM photo crop copyWalter L. Miller, M.D.
Pediatric Endocrinologist
Dr. Walter L. Miller is Professor of Pediatrics and Chief of Endocrinology at the University of California, San Francisco, where he holds joint appointments in the Center for Reproductive Sciences and the Human Genetics Program. Dr. Miller received his S.B. in Philosophy from the Massachusetts Institute of Technology in 1965 and his M.D. from Duke University in 1970. He did two years of residency in pediatrics at the Massachusetts General Hospital, two years of general endocrinology in the USPHS at NIH.

He then moved to San Francisco for a third year of residency, a two-year fellowship in biochemistry and one year of pediatric endocrinology before joining the faculty in 1978. He was promoted to Associate Professor in 1983, to Professor in 1987, and named Division Chief in 2000. Dr. Miller is internationally known for his landmark work in the molecular biology of steroid hormone synthesis. His laboratory cloned many of the genes for steroidogenic enzymes and their co-factors, and elucidated the molecular basis of eight diseases, including three forms of congenital adrenal hyperplasia: due to deficiencies of steroidogenic acute regulatory protein (StAR), the cholesterol side-chain cleavage system (P450scc), and P450 oxidoreductase (POR), as well as recessive Ehlers-Danlos syndrome and pseudo vitamin D-deficiency rickets. His group described the post-translational regulation of androgen synthesis, and has used clinical investigation, molecular and cellular biology, biophysics and computational imaging to study human disease. Dr. Miller was the co-chair of the LWPES/ESPE consensus conference on CAH and principal author of the consensus statement published in 2002. Over 70 students and fellows have trained with Dr. Miller in his laboratory, and another 28 have studied Pediatric Endocrinology under his direction. Dr. Miller has received the Ross Research Award from the Western Society for Pediatric Research, the Edwin B. Astwood Award and the Clinical Investigator Award from the Endocrine Society, the Clinical Endocrinology Trust Medal from the British Endocrine Society, and the Samuel Rosenthal Foundation Prize for Excellence in Academic Pediatrics. Dr. Miller is active in numerous societies and editorial boards, served on the Biochemical Endocrinology Study Section, the Basil O’Connor Advisory Committee of the March of Dimes, and currently serves on the Board of Scientific Counselors of the National Institute of Child Health and Human Development.

maria-newMaria I. New, M.D.

Pediatric and Adult Endocrinologist
Recipient of The Endocrine Society’s highest award, The Koch Award, and a member of the National Academy of Sciences, Dr. Maria New is Professor of Pediatrics and Director of the Adrenal Steroids Disorders Program at Mount Sinai School of Medicine. Dr. New’s research focuses on intersex, childhood hypertension, and adrenal steroid disorders, particularly CAH. She is developing gene therapy for CAH. 

Dr. New is responsible for a number of scientific breakthroughs in the study of CAH. She runs the largest CAH clinic in the United States and one of the largest in the world. It is the only large center that provides prenatal diagnosis of CAH and prenatal treatment of affected females to prevent genital ambiguity. Dr. New’s Laboratory of Molecular Endocrinology is an international resource for molecular genetic diagnosis of many hormone disorders and provides routine DNA analysis of the 21-hydroxylase gene, the mutation of which causes CAH. Dr. New received her M.D. from the University of Pennsylvania, where she was awarded the Distinguished Graduate Award. The many honors Dr. New has received include election to the National Academy of Sciences, the Institute of Medicine of the National Academy of Sciences, and the American Academy of Arts & Sciences. Dr. New has been awarded the MERIT Award of the National Institute of Child Health & Development recognizing her research in adrenal disorders, the Dale Medal of the British Endocrine Society, the General Clinical Research Center Award for Excellence in Clinical Research and the Robert H. Williams Distinguished Leadership Award in Endocrinology. Dr. New has been President of both the Endocrine Society and the Lawson Wilkins Pediatric Endocrine Society and Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism. Among her multiple advisory positions in federal, state, and city organizations, she is presently a member of the New York State Public Health Council and the National Advisory Research Council of the National Institute of Child Health and Human Development.

OBERFIELDSharon E. Oberfield, M.D.

Professor of Pediatrics
Dr. Sharon Oberfield is the Director of the Division of Pediatric Endocrinology, Diabetes and Metabolism and the Program Director of the Fellowship Training Program at Columbia University Medical Center, New York Presbyterian Hospital. In the past Dr. Oberfield has been a Director of the Lawson Wilkins Pediatric Endocrine Society (LWPES) and chaired its Drug and Therapeutics Committee. She is the current Chair of the LWPES Program Directors Committee. Dr. Oberfield is also a member of the Endocrine Society and its Clinical Guidelines Subcommittee. She is the author or co-author of more than 125 articles, multiple chapters and reviews. She is also an invited speaker at national and international meetings on topics related to disorders of the adrenal gland and puberty.

dr_poppasDix P. Poppas, M.D., F.A.A.P., F.A.C.S.
Pediatric Urologist
Dr. Dix Poppas is Chief of Pediatric Urology at the Children’s Hospital of New York – Weill Medical College of Cornell University. Dr. Poppas is the Richard Rodgers Professor of Pediatric Urology in the James Buchanan Brady Department of Urology at Weill Medical College. He holds joint appointments as Professor of Pediatrics and Professor of Plastic and Reconstructive Surgery at Weill Medical College. Dr. Poppas’ practice is limited to pediatric urology with special interest in genital reconstruction, laparoscopy and intersex disorders. He serves as Director of the Laboratory for Minimally Invasive Urologic Surgery. Dr. Poppas is a Diplomat of the American Board of Urology, a Fellow of the American Academy of Pediatrics and a Fellow of the American College of Surgeons. He has published over 60 peer-reviewed manuscripts and over 12 book chapters relating to his clinical and basic science research.


RinkRichard C. Rink, M.D.
Pediatric Urologist
Dr. Richard C. Rink is a graduate of Indiana University School of Medicine. His general surgical training was at Emory University in Atlanta, Georgia. He returned to Indiana University where he completed his Urology Residency.

He then did a Pediatric Urologic Fellowship at The Children’s Hospital, Boston at Harvard Medical School. In 1985, he joined the Pediatric Urology Faculty at the James Whitcomb Riley Hospital for Children at Indiana University. In 1989, was Chief of Pediatric Urology from 1996-2015 and was named the Robert A. Garrett Professor of Pediatric Urologic Research.

Dr. Rink is a member of many prestigious national and international organizations including the American Academy of Pediatrics (AAP), American College of Surgeons, The Society of Pediatric Urology, The European Society of Pediatric Urology, and the American Urologic Association (AUA). He has served on the Executive Committees of the Society of Genitourinary Reconstructive Surgeons (GURS), the American Academy of Pediatrics-Section on Urology, and the North Central Section of the AUA. He is past-president of both the GURS and American Association of Pediatric Urologists. He is President-elect of the AAP-Section on Urology. Dr. Rink has authored or co-authored over 120 journal articles and 20 Textbook chapters. He is co-editor of the new textbook, Pediatric Urology. He and his associates have established one of the premier Pediatric Urologic Fellowship training programs in the world. He has been named one of “The Best Doctors in America” and “America’s Top Rated Physicians.” His primary interest is in pediatric genital reconstructive procedures and reconstruction of the lower urinary tract in children. He has a tremendous amount of experience in reconstruction for Congenital Adrenal Hyperplasia and has reported several innovative surgical techniques for these children. He has lectured throughout the world on this topic

Rivkees photoScott A. Rivkees, M.D.

Pediatric Endocrinologist
Scott A. Rivkees, MD, a board-certified specialist in pediatric endocrinology, is Professor of Pediatrics and Chairman of Pediatrics of the University Florida and Shands Hospital for Children.

Dr. Rivkees received his MD from the University of Medicine and Dentistry of New Jersey, and completed residencies in Pediatrics at Massachusetts General Hospital and Harvard Medical School in Boston. His postgraduate training includes a fellowship in Pediatric Endocrinology at Massachusetts General Hospital and Harvard Medical School in Boston. He also received postdoctoral training in at Massachusetts General Hospital and Harvard Medical School.  Before moving to the University of Florida, Dr. Rivkees was Professor at Yale University.

Dr. Rivkees is the recipient of multiple National Institutes of Health and foundation-sponsored research grants. He has an active clinical and basic science research program. He has published more than 275 original and review articles in scientific journals and serves on multiple editorial boards and National Institutes of Health review panels. Dr. Rivkees is a fellow of the American Academy of Pediatrics and the American Society for Clinical Investigation. Dr. Rivkees also has been an expert witness for the United States Senate Children and Family Subcommittee. Dr. Rivkees is co-author of Congenital Adrenal Hyperplasia: A Parent’s Guide.

ROSS PORTRAITRichard J.M. Ross, Ph.D., M.B.B.S, M.D., F.R.C.P

Richard J.M. Ross is Professor of Endocrinology, Head of Section Endocrinology & Reproduction, Sheffield University.

Professor Ross trained in medicine at The Royal London Hospital (1974-1979) and in Endocrinology at St Bartholomew’s Hospital, London (1983-1988). He is Head of the Section of Endocrinology and Reproduction and serves on the School Council.

Professor Ross’s research and clinical interests are in Pituitary Disease. His research has yielded some 130 papers in peer reviewed journals, over 50 chapters and two books. He has a particular interest in commercial research. He is a Knowledge Transfer Champion in the university, and founding Director of two university spin-out companies; Asterion Ltd and Diurnal Ltd. He has 9 granted patents and over 100 filed patents and obtained Orphan Drug Designation from the EMEA for Chronocort; a new therapy for Adrenal Insufficiency.

SANDBERG_David4x5David E. Sandberg, Ph.D.

Pediatric Psychologist
Dr. David Sandberg is Associate Professor and Director of the Division of Child Behavioral Health in the Department of Pediatrics and Communicable Diseases at the University of Michigan in Ann Arbor.

Dr. Sandberg is a child and adolescent clinical psychologist with expertise in caring for youths with chronic medical conditions and their families. 

For over 18 years, he has served as a member of healthcare professional teams caring for youths with various endocrine conditions. His clinical research program flows from these clinical experiences, including studies of the psychosocial aspects of short stature and examination of assumptions underlying growth hormone therapy. A second focus is the psychological development of children born with conditions identified by newborn screening. He has developed a psychoeducational treatment manual for clinicians caring for newborns with congenital adrenal hyperplasia and is designing health-related quality-of-life questionnaires for patients with conditions affecting sexual or reproductive function and their parents. Dr. Sandberg obtained his doctorate from Concordia University in Montreal, Canada and completed postdoctoral fellowships at the University of Miami and at the College of Physicians & Surgeons of Columbia University. He is a member of the Lawson Wilkins Pediatric Endocrine Society, is a Fellow of the American Psychological Association and the Society of Pediatric Psychology, and is on the editorial board of the Journal of Pediatric Psychology.


seelyEllen W. Seely, M.D.
Adult Endocrinologist
Ellen W. Seely, M.D. is the Director of Clinical Research, in the Division of Endocrinology, Diabetes and Hypertension at the Brigham and Women’s Hospital in Boston, Massachusetts and Associate Professor of Medicine at Harvard Medical School.

Dr. Seely is a graduate of Brown University, and she received her medical degree from Columbia University’s College of Physicians and Surgeons. She then completed her internal medicine and endocrinology fellowship training at Brigham and Women’s Hospital.

Dr. Seely is a leader in patient-oriented research of the physiology of blood pressure regulation in women during pregnancy and following menopause. Her research has focused on understanding cardiovascular risk factors in women. She is the principal investigator on three NIH projects. She is a committed mentor and won the 2001 A. Clifford Barger Award in Excellence in Mentoring from Harvard Medical School. She currently serves on the Research Affairs Committee of the Endocrine Society and the Cardiovascular Endocrinology Task Force. Clinically, she sees women with endocrine problems complicating pregnancy. She has lectured widely on CAH and pregnancy. Dr. Seely is also a Fellow of the Council for High Blood Pressure Research of the American Heart Association and has been designated a Clinical Specialist in hypertension by the American Society of Hypertension. She serves on the editorial board of the Journal of Endocrinology and Metabolism and has been selected for inclusion in Who’s Who in Medicine and Healthcare, and Who’s Who in America. She has been named one of Boston’s Top Doctors for Women in Endocrinology, Boston Magazine, 2001.


Phyllis W. Speiser, M.D.
Pediatric Endocrinologist
Dr. Phyllis Speiser is Director of Pediatric Endocrinology for the North Shore-Long Island Jewish Health System in New York and Professor of Clinical Pediatrics at New York University School of Medicine.

Dr. Speiser is an internationally recognized expert in congenital adrenal hyperplasia (CAH). Her research has mainly focused on genetic and clinical correlations among patients with adrenal disorders. Dr. Speiser’s research on CAH has been published in the New England Journal of Medicine, the Journal of Clinical Investigation and the Journal of Endocrinology and Metabolism, where she serves on the Editorial Board. Dr. Speiser recently edited and published a symposium on congenital adrenal hyperplasia for the Endocrine and Metabolism Clinics of North America. She is a medical advisor to the National Adrenal Diseases Foundation.

therellBradford L. Therrell, M.S., Ph.D.

Dr. Brad Therrell is a Professor in the Department of Pediatrics at the University of Texas Health Science Center at San Antonio (UTHSCSA), and Director of the National Newborn Screening and Genetics Resource Center (NNSGRC) located in Austin, Texas.

Dr. Therrell previously served for almost 30 years as Director of Chemistry at the Texas Department of Health, where he was responsible for the world’s largest newborn screening laboratory. It was under his direction that congenital adrenal hyperplasia (CAH) was added to the newborn screening panel in Texas in 1987.

Dr. Therrell earned his bachelor’s degree in chemistry from Mississippi College in Clinton, and his master’s and doctoral degrees in inorganic chemistry from the Florida State University in Tallahassee. In 1997, he was presented with an Honorary Doctor of Medicine Degree from Kunming Medical College in Yunnan, China, for his outstanding contributions to the field of newborn screening and for his leadership and cooperation in establishing newborn screening in developing countries. Dr. Therrell became interested in CAH screening after learning of successful screening efforts in Alaska and Illinois. He collaborated with Dr. Sheri Berenbaum, also a member of the CARES Foundation Board, in accumulating CAH newborn screening information from over 1.8 million Texas newborns in a major published study. Dr. Therrell has served as co-editor of the journal, Screening, and is a member of the editorial board of the journals, Genetic Testing and Journal of Medical Screening. He is a member of committees concerned with newborn screening issues that are part of the March of Dimes, the Association of Public Health Laboratory Directors, the American College of Medical Genetics, HRSA and the Centers for Disease Control and Prevention (CDC). Additionally, he has authored or co-authored over 120 articles and several book chapters and has edited several books on newborn screening topics.


vogiatziMaria Vogiatzi, M.D.
Pediatric Endocrinologist
Dr. Vogiatzi is currently Associate Professor of Pediatrics CE, and Director of the Adrenal and Puberty Center, Division of Endocrinology and Diabetes at Children’s Hospital of Philadelphia. A native of Greece, Dr. Vogiatzi graduated from the Medical School of Aristotelian University in Greece and came to New York for further training in Pediatrics. She continued her training in Pediatric Endocrinology at The New York Hospital/Cornell and Baylor College of Medicine in Houston, TX. She joined the faculty of Pediatric Endocrinology at Cornell in 1997 and became the director of the program in 2005.

Dr. Vogiatzi has been involved with patients with CAH and their families since she joined Cornell. She worked with Dr. New’s team in a study of growth in CAH and in evaluating the long term outcome of males with classical CAH. Her research interests include studies of growth in CAH, the development of a model of comprehensive, multidisciplinary care in CAH and other chronic endocrine disorders and studies of low bone mass (i.e. osteoporosis) in childhood and adolescence.

witchelSelma Feldman Witchel, M.D.

Pediatric Endocrinologist
Dr. Selma Witchel is an Associate Professor of Pediatrics at the Children’s Hospital of UPMC, University of Pittsburgh, Pittsburgh, PA where she also serves as the Program Director of the Pediatric Endocrine Fellowship Program.

She is a graduate of Oberlin College and the University of Pittsburgh School of Medicine. Following her residency in pediatrics at the Children’s Hospital Medical Center in Cincinnati, Ohio, she completed her pediatric endocrine fellowship at the Children’s Hospital of Pittsburgh.

Dr. Witchel has a long-standing interest in the diagnosis and management of congenital adrenal hyperplasia. She has published many research articles, reviews, and chapters about congenital adrenal hyperplasia, ambiguous genitalia, genetics of disorders associated with androgen excess, and polycystic ovary syndrome. She is a member of the Endocrine Society, Lawson Wilkins Pediatric Society, American Pediatric Society, and the Androgen Excess Society.